CHRU Lille Hospital Claude Huriez ( Site 0200)
Lille
0 studies enrolling now · 1 studies all time
What they study most
Multiple Myeloma
Studies at this site
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)
— Withdrawn before enrolling